IP Verse

APOTEX INC. et al. v. Regeneron Pharmaceuticals, Inc. - IPR2022-00301

Explore the PTAB proceeding IPR2022-00301 filed by APOTEX INC. et al. against Regeneron Pharmaceuticals, Inc. on Dec 9, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2022-00301
Filing Date
Dec 9, 2021
Petitioner
APOTEX INC. et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Final Written Decision
Respondent Application Number
14972560
Respondent Tech Center
1600
Respondent Patent Number
9669069
Institution Decision Date
Feb 9, 2022
Termination Date
Nov 9, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2022-00301.

TypeName
Petitioner CounselRea, Teresaet al
Respondent CounselFishman, Deborahet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.